Bedrijfsoverzicht
Agilon Health, Inc. operates as a provider of healthcare services specifically tailored for senior populations by deploying primary care physicians within communities across the United States. The company utilizes a subscription-based business model, often referred to as per-member per-month, to manage the comprehensive healthcare needs of its patient base. This entity functions within the Healthcare sector and specifically targets the Medical Care Facilities industry, positioning itself to address the growing demand for accessible senior care infrastructure. With a market capitalization of $315.85M and an annual revenue of $5.93B over the trailing twelve months, the company demonstrates significant operational scale supported by a workforce of 856 employees. These financial figures indicate that while the firm has established a substantial revenue base, the market capitalization relative to revenue suggests a valuation environment where investors are pricing in future profitability adjustments rather than current earnings power.
Financiële gezondheid
The company reported a revenue of $5.93B for the trailing twelve months, yet it posted a net income of $-405,347,008 and an EBITDA of $-406,182,016, revealing a cost structure where expenses significantly exceed gross revenue generation. This substantial gap between top-line revenue and net income highlights a challenging operational environment where high fixed costs or low gross margins are eroding profitability at a severe rate. The firm generated free cash flow of $-81,226,128, which indicates a cash burn situation that limits immediate financial flexibility and necessitates reliance on existing cash reserves or external capital markets to fund operations. Analyzing the three primary margins shows a gross margin of -2.7%, an operating margin of -10.0%, and a profit margin of -6.6%, all of which signal that the company is currently operating at a loss across all levels of profitability measurement. Regarding liquidity and leverage, the company holds $285.14M in cash against a debt load of $36.81M, resulting in a debt-to-equity ratio of 29.05 that suggests a leveraged balance sheet despite the high cash balance. The current ratio stands at 1.02, indicating that the company possesses just enough current assets to cover its current liabilities, which points to a tight but technically sufficient short-term liquidity position. Furthermore, the return on equity is recorded at -135.6% and the return on assets at -17.5%, metrics that reveal that management effectiveness in generating returns on shareholder capital and asset base is currently negative.
Waarderingsbeoordeling
Valuation metrics for agilon health, inc. present a complex picture with a trailing P/E ratio of N/A due to the lack of positive earnings, while the forward P/E is calculated at -4.71. The divergence between a non-existent trailing multiple and a negative forward multiple implies that the market is not valuing the company based on historical profitability but is instead assessing it on anticipated future earnings trajectories that must turn positive to eliminate the negative multiple. The price-to-book ratio is 2.49, indicating that the market is currently pricing the company at a premium of roughly 2.5 times its book value, despite the underlying losses. Alternative valuation measures such as the price-to-sales ratio of 0.05 and an EV/EBITDA of -0.17 suggest that the market is applying a very low multiple to revenue and effectively negative earnings power, reflecting high risk in the current financial profile. In terms of trading ranges, the 52-week high is $144.25 and the 52-week low is $7.48, meaning the current trading price sits significantly below the yearly peak and reflects a sharp decline from previous highs. The beta of 0.33 indicates that the stock exhibits low volatility relative to the broader market, suggesting that price movements are less sensitive to general market fluctuations compared to the average equity.
Growth & Income
Agilon Health, Inc. demonstrated a revenue growth rate of 3.1% year-over-year, while the earnings growth rate is N/A due to the continued negative net income position. The fact that earnings growth is non-existent while revenue is growing implies that the company is expanding its top line but failing to convert that expansion into profitable earnings, a common scenario during heavy investment phases or in businesses with high initial burn rates. As a non-dividend payer, the company currently does not distribute a dividend yield, which is N/A, nor does it have a payout ratio, as the payout ratio is 0.0%. This absence of dividend distribution indicates that the company retains all earnings, if any were generated, or burns cash to reinvest into its healthcare platform and operational capabilities rather than returning capital to shareholders. The overall growth and income profile is characterized by steady revenue expansion of 3.1% that is currently decoupled from profitability, with no income generation through dividends to support shareholder yield.